What other stocks do shareholders of Lexaria Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Cross Timbers Royalty Trust (CRT) , InfraCap MLP ETF (AMZA) , Alliance Resource Partners (ARLP) , CRISPR Therapeutics (CRSP) , KushCo (KSHB) , Brigham Minerals (MNRL) , Vapor Group (VPOR) and Arbor Realty Trust (ABR) .

How do I buy shares of Lexaria Bioscience?

Shares of LXX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

CNSX:LXX

Lexaria Bioscience (LXX) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free LXX Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 48,200 shs
Average Volume: 250,001 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Lexaria Bioscience alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Lexaria Bioscience Stock (CNSX:LXX)

Lexaria Bioscience Corp. focuses on the development of its proprietary nutrient infusion technologies for the production of superfoods. It operates in two segments, Intellectual Property Licensing and Consumer Products. The company develops and licenses DehydraTECH, a patented lipid nutrient infusion technology that improves taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins, NSAIDs, nicotine, and other molecules. It is also involved in the development, production, and distribution of enhanced functional food and supplement products under the ViPova and Lexaria Energy brands. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was founded in 2004 and is based in Kelowna, Canada.

Ad Crypto 101 Media

SHOCKING Crypto Leak…

Claim your free seat by clicking here now.

LXX Stock News Headlines

April 9, 2024 | msn.com

LEXX Stock Earnings: Lexaria Bioscience Beats EPS for Q2 2024

February 22, 2024 | benzinga.com

Lexaria Bioscience Stock (NASDAQ:LEXXW) Dividends: History, Yield and Dates

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

January 30, 2024 | msn.com

Lexaria submits IND to begin Phase 1b study of DehyraTECH-CBD

December 1, 2023 | markets.businessinsider.com

Buy Rating on Lexaria Bioscience: Promising DehydraTECH Study and Market Potential

November 27, 2023 | msn.com

Lexaria stock rallies 20% on positive GLP-1 drug delivery study

July 22, 2023 | msn.com

Maxim Group Initiates Coverage of Lexaria Bioscience (LEXX) with Buy Recommendation

June 16, 2023 | benzinga.com

Lexaria's DehydraTECH-CBD Lowers Blood Glucose Levels in Diabetes Animal Study

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

May 12, 2023 | marketwatch.com

CannabisNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting

May 9, 2023 | benzinga.com

Lexaria Bioscience shares are trading lower after the company priced a 2.1 million unit offering at $0.95 per unit.

May 9, 2023 | msn.com

Lexaria Bioscience prices $2.0M stock offering

May 8, 2023 | benzinga.com

Lexaria's Human Clinical Nicotine Study Completes Dosing as Planned

April 26, 2023 | finance.yahoo.com

LEXX: DehydraTECH CBD May Offer New Mechanism of Action

March 4, 2023 | finanznachrichten.de

Lexaria Bioscience Corp.: Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels

February 22, 2023 | nasdaq.com

Lexaria Bioscience Corp. Common Stock (LEXX)

September 26, 2022 | finance.yahoo.com

Lexaria Bioscience Corp. (LEXX)

August 31, 2022 | finance.yahoo.com

Lexaria Receives New Patent in Mexico

August 12, 2022 | marketwatch.com

NetworkNewsAudio - Lexaria Bioscience Corp. (NASDAQ: LEXX) Pioneering Innovative Hypertension Treatments

August 12, 2022 | marketwatch.com

CannabisNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Positive FDA Feedback Concerning Opening IND Program

August 11, 2022 | apnews.com

Lexaria Bioscience Corp. (NASDAQ: LEXX) Focused on Filling Need for Hypertension Treatment Solution

August 11, 2022 | finance.yahoo.com

Lexaria Discusses Valuation Metrics for Biotech Industry

August 10, 2022 | finance.yahoo.com

Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension

July 27, 2022 | msn.com

Lexaria's DehydraTECH CBD Hypertension Study Dosing Complete With No Serious Adverse Events

June 21, 2022 | finance.yahoo.com

Lexaria Signs Manufacturing and License Agreements with BevNology

June 21, 2022 | seekingalpha.com

Lexaria stock soars 19% on 2 manufacturing/license agreements with BevNology

June 3, 2022 | seekingalpha.com

Lexaria inks licensing deal for drug delivery tech with Premier Wellness for Japanese market

See More Headlines

Receive LXX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CNSX
Sector: Consumer Defensive
Industry: Packaged Foods
Sub-Industry: N/A
Current Symbol: CNSX:LXX
CUSIP: N/A
CIK: N/A
Web: www.lexariaenergy.com
Phone: 250-765-6424
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. Christopher A. Bunka (Age 57)
Chairman & CEO
Mr. John M. Docherty (Age 50)
Pres & Director
Mr. Allan Spissinger (Age 50)
CFO, Corp. Sec. & Treasurer
Mr. Alex Blanchard
Mang. Corp. Communications & Investor Relations
Dr. Edward Ergenzinger
Chief Legal Officer & Sr. VP of Innovation

Key Competitors

View All Competitors

LXX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Lexaria Bioscience own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), CRISPR Therapeutics (CRSP), KushCo (KSHB), Brigham Minerals (MNRL), Vapor Group (VPOR) and Arbor Realty Trust (ABR).
How do I buy shares of Lexaria Bioscience?: Shares of LXX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:LXX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Lexaria Bioscience (LXX) Stock Price, News & Analysis

About Lexaria Bioscience Stock (CNSX:LXX)

LXX Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

LXX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info